Table 1.
Baseline patient characteristics (n = 13).
Gender, n (%) | |
---|---|
Male | 9 (69.2%) |
Female | 4 (30.8%) |
Age (years) | |
Mean (Std. Dev.) | 65.8 (9.99) |
Median (Range) | 67.0 (45-83) |
Race, n (%) | |
Asian | 5 (38.5%) |
Black or African-American | 1 (7.7%) |
White or Caucasian | 7 (53.8%) |
Disease Status at Enrollment, n (%) | |
Relapsed | 10 (76.9%) |
Refractory | 3 (23.1%) |
ECOG Performance Status, n (%) | |
0 | 8 (61.5%) |
1 | 4 (30.8%) |
2 | 1 (7.7%) |
Prior Therapies, n (%) | |
Chemotherapy | 13 (100.0%) |
Radiotherapy | 4 (30.8%) |
HCT | 0 |
Prior Lines of Chemotherapy | |
Median (Interquartile Range) | 4 (3-10) |
Abbreviations: ECOG = Eastern Cooperative Oncology Group; HCT = hematopoietic cell transplantation; Std. Dev. = standard deviation.